SEPTInvestingStart Free

DTIL 8-K: Secondary offering

Precision BioSciences

Filed with the SEC on · accession 0001628280-26-071867

DTIL filed a 8-K (current report) with the SEC on Nov 9, 2026. Precision BioSciences announced the pricing of an underwritten offering of 10,235,077 shares of common stock at $7.75 per share, plus pre-funded warrants to purchase up to 5,893,964 shares at $7.749995 per warrant.

Summary of the filing

Precision BioSciences announced the pricing of an underwritten offering of 10,235,077 shares of common stock at $7.75 per share, plus pre-funded warrants to purchase up to 5,893,964 shares at $7.749995 per warrant. The company expects net proceeds to extend its cash runway into Q4 2029, funding its PBGENE-HBV and PBGENE-DMD clinical programs.

For details, click here →How to read a 8-K →

Key details

Shares of common stock offeredshares 10.2M
Offering price per share of common stock$8
Pre-funded warrants offered (shares underlying)shares 5.9M
Offering price per pre-funded warrant$8
Gross proceeds from common stock (calculated)$79.3M
Gross proceeds from pre-funded warrants (calculated)$45.7M
Total gross proceeds (calculated)$125.0M
IssuerPrecision BioSciences, Inc.
Chief financial officerNaresh Tanna

✦ Ask GOAX AI about this filing — what it means for DTIL, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for DTIL?

Click here

Frequently asked questions

What did DTIL file with the SEC on Nov 9, 2026?

DTIL filed a 8-K (Secondary offering). Precision BioSciences announced the pricing of an underwritten offering of 10,235,077 shares of common stock at $7.75 per share, plus pre-funded warrants to purchase up to 5,893,964 shares at $7.749995 per warrant. The company expects net proceeds to extend its cash runway into Q4 2029, funding its PBGENE-HBV and PBGENE-DMD clinical programs.

What does a secondary offering mean for DTIL stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other DTIL SEC filings

Get alerts when DTIL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
DTIL overviewDTIL analysisDTIL newsLatest SEC filings